Tags
Language
Tags
March 2024
Su Mo Tu We Th Fr Sa
25 26 27 28 29 1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31 1 2 3 4 5 6

Financing Technology's Frontier: Decision-Making Models for Investors and Advisors, Second Edition (repost)

Posted By: interes
Financing Technology's Frontier: Decision-Making Models for Investors and Advisors, Second Edition (repost)

Financing Technology's Frontier: Decision-Making Models for Investors and Advisors, Second Edition by Richard P. Shanley
English | 2003 | ISBN: 0471444324 | 272 pages | PDF | 1 MB

Praise for Financing Technology’s Frontier
Second Edition

"Today, developments in biotechnology are converging with demographics, third world markets, the maturation of care management and consumer empowerment to assure us a totally transformed health care and life sciences industry in the next five years.

Financial advisors with worldwide knowledge sharing and tightly linked practice networks to meet demands–– not only in the U.S., Europe, Australia, and Japan, but in changing markets in China, Latin America, and Africa–– will be the preferred advisors of the future.
Rich Shanley, Partner in our tri-state healthcare and life sciences practice, is such an advisor and with this book, takes the reader through the real world of financing companies at the cutting edge of technological innovation. Financing Technology’s Frontier is an important reference for anyone interested in the future of the rapidly evolving technology."
–– Robert Go
Global Leader, Life Sciences, Deloitte Touche Tohmatsu

"Financing Technology’s Frontier is an excellent guide for investors who are seeking to be on the ground level of cutting edge and often overlooked investment opportunities, such as New York City’s burgeoning biotech industry."
–– Maria Gotsch
Senior Vice President, New York City Investment Fund

"There’s more than one way to raise money for biotech businesses, and Richard Shanley understands that. In this new edition of Financing Technology's Frontier, he takes a serious look at what bioparks and academic medical centers are doing to encourage the innovations and breakthroughs that will constitute the cutting edge of the life sciences arena for years to come."
–– Dr. William Polf
Senior Vice President, New York-Presbyterian Hospital